334 related articles for article (PubMed ID: 9679924)
1. Detection of deletions in the short arm of chromosome 3 in uncultured renal cell carcinomas by interphase cytogenetics.
Siebert R; Jacobi C; Matthiesen P; Zühlke-Jenisch R; Potratz C; Zhang Y; Stöckle M; Klöppel G; Grote W; Schlegelberger B
J Urol; 1998 Aug; 160(2):534-9. PubMed ID: 9679924
[TBL] [Abstract][Full Text] [Related]
2. Characterization of quantitative chromosomal abnormalities in renal cell carcinomas by interphase four-color fluorescence in situ hybridization.
Receveur AO; Couturier J; Molinié V; Vieillefond A; Desangles F; Guillaud-Bataille M; Danglot G; Coullin P; Bernheim A
Cancer Genet Cytogenet; 2005 Apr; 158(2):110-8. PubMed ID: 15796957
[TBL] [Abstract][Full Text] [Related]
3. Histopathological, cytogenetic, and molecular characterization of renal cortical tumors.
Presti JC; Rao PH; Chen Q; Reuter VE; Li FP; Fair WR; Jhanwar SC
Cancer Res; 1991 Mar; 51(5):1544-52. PubMed ID: 1671759
[TBL] [Abstract][Full Text] [Related]
4. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
[TBL] [Abstract][Full Text] [Related]
6. Numerical aberrations of chromosomes 1 and 7 in renal cell carcinomas as detected by interphase cytogenetics.
Beck JL; Hopman AH; Feitz WF; Schalken J; Schaafsma HE; Van de Kaa CA; Ramaekers FC; Hanselaar AG; De Wilde PC
J Pathol; 1995 Jun; 176(2):123-35. PubMed ID: 7636622
[TBL] [Abstract][Full Text] [Related]
7. PCR-based RFLP screening of the commonly deleted 3p loci in renal cortical neoplasms.
el-Naggar AK; Batsakis JG; Wang G; Lee MS
Diagn Mol Pathol; 1993 Dec; 2(4):269-76. PubMed ID: 7906993
[TBL] [Abstract][Full Text] [Related]
8. Allelic deletions in renal tumors: histopathological correlations.
Presti JC; Reuter VE; Cordon-Cardo C; Mazumdar M; Fair WR; Jhanwar SC
Cancer Res; 1993 Dec; 53(23):5780-3. PubMed ID: 8242636
[TBL] [Abstract][Full Text] [Related]
9. Deletion mapping in human renal cell carcinoma.
Bergerheim U; Nordenskjöld M; Collins VP
Cancer Res; 1989 Mar; 49(6):1390-6. PubMed ID: 2924296
[TBL] [Abstract][Full Text] [Related]
10. Interphase cytogenetics of multicentric renal cell tumours confirm associations of specific aberrations with defined cytomorphologies.
Amo-Takyi BK; Mittermayer C; Günther K; Handt S
Br J Cancer; 2000 Apr; 82(8):1407-14. PubMed ID: 10780519
[TBL] [Abstract][Full Text] [Related]
11. Allelic loss at chromosome 3p characterizes clear cell phenotype of renal cell carcinoma.
Ogawa O; Kakehi Y; Ogawa K; Koshiba M; Sugiyama T; Yoshida O
Cancer Res; 1991 Feb; 51(3):949-53. PubMed ID: 1671000
[TBL] [Abstract][Full Text] [Related]
12. Renal cell carcinoma of end-stage renal disease: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification.
Hughson MD; Bigler S; Dickman K; Kovacs G
Mod Pathol; 1999 Mar; 12(3):301-9. PubMed ID: 10102616
[TBL] [Abstract][Full Text] [Related]
13. Frequent breakpoints in the region surrounding FRA3B in sporadic renal cell carcinomas.
Shridhar V; Wang L; Rosati R; Paradee W; Shridhar R; Mullins C; Sakr W; Grignon D; Miller OJ; Sun QC; Petros J; Smith DI
Oncogene; 1997 Mar; 14(11):1269-77. PubMed ID: 9178887
[TBL] [Abstract][Full Text] [Related]
14. Identification of tumor entities of renal cell carcinoma using interphase fluorescence in situ hybridization.
Sanjmyatav J; Rubtsov N; Starke H; Schubert J; Hindermann W; Junker K
J Urol; 2005 Aug; 174(2):731-5. PubMed ID: 16006966
[TBL] [Abstract][Full Text] [Related]
15. The application of cytogenetics and fluorescence in situ hybridization to fine-needle aspiration in the diagnosis and subclassification of renal neoplasms.
Roh MH; Dal Cin P; Silverman SG; Cibas ES
Cancer Cytopathol; 2010 Jun; 118(3):137-45. PubMed ID: 20544709
[TBL] [Abstract][Full Text] [Related]
16. Loss of chromosomes in clear cell renal cell carcinoma and in corresponding renal parenchyma.
Feil G; Leipoldt M; Nelde HJ; Wunderer A; Wechsel HW; Kaiser P; Bichler KH
Anticancer Res; 1999; 19(2C):1477-82. PubMed ID: 10365127
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic and interphase cytogenetic analysis of papillary (chromophilic) renal cell carcinoma.
Kattar MM; Grignon DJ; Wallis T; Haas GP; Sakr WA; Pontes JE; Visscher DW
Mod Pathol; 1997 Nov; 10(11):1143-50. PubMed ID: 9388066
[TBL] [Abstract][Full Text] [Related]
18. Terminal deletion of chromosome 3p sequences in nonpapillary renal cell carcinomas: a breakpoint cluster between loci D3S1285 and D3S1603.
Wilhelm M; Bugert P; Kenck C; Staehler G; Kovacs G
Cancer Res; 1995 Nov; 55(22):5383-5. PubMed ID: 7585605
[TBL] [Abstract][Full Text] [Related]
19. Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events.
Gronwald J; Störkel S; Holtgreve-Grez H; Hadaczek P; Brinkschmidt C; Jauch A; Lubinski J; Cremer T
Cancer Res; 1997 Feb; 57(3):481-7. PubMed ID: 9012478
[TBL] [Abstract][Full Text] [Related]
20. Detailed genetic and physical map of the 3p chromosome region surrounding the familial renal cell carcinoma chromosome translocation, t(3;8)(p14.2;q24.1).
LaForgia S; Lasota J; Latif F; Boghosian-Sell L; Kastury K; Ohta M; Druck T; Atchison L; Cannizzaro LA; Barnea G
Cancer Res; 1993 Jul; 53(13):3118-24. PubMed ID: 8319219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]